The role of host (endogenous) T cells in chronic graft-versus-host autoimmune disease

Fangqi Chen, Michael A. Maldonado, Michael P. Madaio, Robert A. Eisenberg

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Chronic graft-vs-host (cGVH) disease induced by the transfer of Ia- incompatible spleen cells from one normal mouse strain (such as B6.C- H2(bm12)/KhEg (bm12)) to another (such as C57BL/6) causes an autoimmune syndrome resembling systemic lupus erythematosus (SLE). The role of host- derived T cells in this response is not obvious. Previous reports suggested that host T cells might serve to down-regulate the autoimmune syndrome. To address this issue more definitively, we used CD4 knockout (KO) or CD8KO C57BL/6 (B6) mice as recipients in the bm12→C57B6 cGVH model. CD4KO B6 mice injected with allogeneic bm12 spleen cells (bm12→CD4KO group) showed no evidence of cGVH disease. They made no detectable autoantibodies, including anti-chromatin, anti-dsDNA, anti-ssDNA, and rheumatoid factor. They survived at least 20 wks after induction of cGVH disease; and they did not develop nephritis, based on the absence of detectable levels of proteinuria and normal renal histology at the time of sacrifice. By contrast, CD8KO B6 mice (bm12→CD8KO group) and normal B6 mice (bm12→B6 group) injected with bm12 spleen cells generally showed similar levels of mortality, nephritis, and autoantibodies, although the autoantibody titers declined somewhat after week 8 in the bm12→CD8KO group. Control groups of recipients injected with B6 spleen cells showed no induction of autoantibodies. A surprising finding, however, was that the B6→CD8KO group developed severe histologic glomerulonephritis in the absence of autoantibodies and with decreased immune deposits. These results indicate that endogenous (host) CD4+ T cells play an essential role in the cGVH autoimmune syndrome.

Original languageEnglish (US)
Pages (from-to)5880-5885
Number of pages6
JournalJournal of Immunology
Volume161
Issue number11
StatePublished - Dec 1 1998
Externally publishedYes

Fingerprint

Graft vs Host Disease
Autoantibodies
Autoimmune Diseases
T-Lymphocytes
Spleen
Nephritis
Transplants
Rheumatoid Factor
Glomerulonephritis
Proteinuria
Systemic Lupus Erythematosus
Chromatin
Histology
Down-Regulation
Kidney
Control Groups
Mortality

ASJC Scopus subject areas

  • Immunology

Cite this

Chen, F., Maldonado, M. A., Madaio, M. P., & Eisenberg, R. A. (1998). The role of host (endogenous) T cells in chronic graft-versus-host autoimmune disease. Journal of Immunology, 161(11), 5880-5885.

The role of host (endogenous) T cells in chronic graft-versus-host autoimmune disease. / Chen, Fangqi; Maldonado, Michael A.; Madaio, Michael P.; Eisenberg, Robert A.

In: Journal of Immunology, Vol. 161, No. 11, 01.12.1998, p. 5880-5885.

Research output: Contribution to journalArticle

Chen, F, Maldonado, MA, Madaio, MP & Eisenberg, RA 1998, 'The role of host (endogenous) T cells in chronic graft-versus-host autoimmune disease', Journal of Immunology, vol. 161, no. 11, pp. 5880-5885.
Chen F, Maldonado MA, Madaio MP, Eisenberg RA. The role of host (endogenous) T cells in chronic graft-versus-host autoimmune disease. Journal of Immunology. 1998 Dec 1;161(11):5880-5885.
Chen, Fangqi ; Maldonado, Michael A. ; Madaio, Michael P. ; Eisenberg, Robert A. / The role of host (endogenous) T cells in chronic graft-versus-host autoimmune disease. In: Journal of Immunology. 1998 ; Vol. 161, No. 11. pp. 5880-5885.
@article{6bdb5acdb226420f85e201a147f83978,
title = "The role of host (endogenous) T cells in chronic graft-versus-host autoimmune disease",
abstract = "Chronic graft-vs-host (cGVH) disease induced by the transfer of Ia- incompatible spleen cells from one normal mouse strain (such as B6.C- H2(bm12)/KhEg (bm12)) to another (such as C57BL/6) causes an autoimmune syndrome resembling systemic lupus erythematosus (SLE). The role of host- derived T cells in this response is not obvious. Previous reports suggested that host T cells might serve to down-regulate the autoimmune syndrome. To address this issue more definitively, we used CD4 knockout (KO) or CD8KO C57BL/6 (B6) mice as recipients in the bm12→C57B6 cGVH model. CD4KO B6 mice injected with allogeneic bm12 spleen cells (bm12→CD4KO group) showed no evidence of cGVH disease. They made no detectable autoantibodies, including anti-chromatin, anti-dsDNA, anti-ssDNA, and rheumatoid factor. They survived at least 20 wks after induction of cGVH disease; and they did not develop nephritis, based on the absence of detectable levels of proteinuria and normal renal histology at the time of sacrifice. By contrast, CD8KO B6 mice (bm12→CD8KO group) and normal B6 mice (bm12→B6 group) injected with bm12 spleen cells generally showed similar levels of mortality, nephritis, and autoantibodies, although the autoantibody titers declined somewhat after week 8 in the bm12→CD8KO group. Control groups of recipients injected with B6 spleen cells showed no induction of autoantibodies. A surprising finding, however, was that the B6→CD8KO group developed severe histologic glomerulonephritis in the absence of autoantibodies and with decreased immune deposits. These results indicate that endogenous (host) CD4+ T cells play an essential role in the cGVH autoimmune syndrome.",
author = "Fangqi Chen and Maldonado, {Michael A.} and Madaio, {Michael P.} and Eisenberg, {Robert A.}",
year = "1998",
month = "12",
day = "1",
language = "English (US)",
volume = "161",
pages = "5880--5885",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "11",

}

TY - JOUR

T1 - The role of host (endogenous) T cells in chronic graft-versus-host autoimmune disease

AU - Chen, Fangqi

AU - Maldonado, Michael A.

AU - Madaio, Michael P.

AU - Eisenberg, Robert A.

PY - 1998/12/1

Y1 - 1998/12/1

N2 - Chronic graft-vs-host (cGVH) disease induced by the transfer of Ia- incompatible spleen cells from one normal mouse strain (such as B6.C- H2(bm12)/KhEg (bm12)) to another (such as C57BL/6) causes an autoimmune syndrome resembling systemic lupus erythematosus (SLE). The role of host- derived T cells in this response is not obvious. Previous reports suggested that host T cells might serve to down-regulate the autoimmune syndrome. To address this issue more definitively, we used CD4 knockout (KO) or CD8KO C57BL/6 (B6) mice as recipients in the bm12→C57B6 cGVH model. CD4KO B6 mice injected with allogeneic bm12 spleen cells (bm12→CD4KO group) showed no evidence of cGVH disease. They made no detectable autoantibodies, including anti-chromatin, anti-dsDNA, anti-ssDNA, and rheumatoid factor. They survived at least 20 wks after induction of cGVH disease; and they did not develop nephritis, based on the absence of detectable levels of proteinuria and normal renal histology at the time of sacrifice. By contrast, CD8KO B6 mice (bm12→CD8KO group) and normal B6 mice (bm12→B6 group) injected with bm12 spleen cells generally showed similar levels of mortality, nephritis, and autoantibodies, although the autoantibody titers declined somewhat after week 8 in the bm12→CD8KO group. Control groups of recipients injected with B6 spleen cells showed no induction of autoantibodies. A surprising finding, however, was that the B6→CD8KO group developed severe histologic glomerulonephritis in the absence of autoantibodies and with decreased immune deposits. These results indicate that endogenous (host) CD4+ T cells play an essential role in the cGVH autoimmune syndrome.

AB - Chronic graft-vs-host (cGVH) disease induced by the transfer of Ia- incompatible spleen cells from one normal mouse strain (such as B6.C- H2(bm12)/KhEg (bm12)) to another (such as C57BL/6) causes an autoimmune syndrome resembling systemic lupus erythematosus (SLE). The role of host- derived T cells in this response is not obvious. Previous reports suggested that host T cells might serve to down-regulate the autoimmune syndrome. To address this issue more definitively, we used CD4 knockout (KO) or CD8KO C57BL/6 (B6) mice as recipients in the bm12→C57B6 cGVH model. CD4KO B6 mice injected with allogeneic bm12 spleen cells (bm12→CD4KO group) showed no evidence of cGVH disease. They made no detectable autoantibodies, including anti-chromatin, anti-dsDNA, anti-ssDNA, and rheumatoid factor. They survived at least 20 wks after induction of cGVH disease; and they did not develop nephritis, based on the absence of detectable levels of proteinuria and normal renal histology at the time of sacrifice. By contrast, CD8KO B6 mice (bm12→CD8KO group) and normal B6 mice (bm12→B6 group) injected with bm12 spleen cells generally showed similar levels of mortality, nephritis, and autoantibodies, although the autoantibody titers declined somewhat after week 8 in the bm12→CD8KO group. Control groups of recipients injected with B6 spleen cells showed no induction of autoantibodies. A surprising finding, however, was that the B6→CD8KO group developed severe histologic glomerulonephritis in the absence of autoantibodies and with decreased immune deposits. These results indicate that endogenous (host) CD4+ T cells play an essential role in the cGVH autoimmune syndrome.

UR - http://www.scopus.com/inward/record.url?scp=0032403548&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032403548&partnerID=8YFLogxK

M3 - Article

VL - 161

SP - 5880

EP - 5885

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 11

ER -